{
    "doi": "https://doi.org/10.1182/blood-2021-153440",
    "article_title": "Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia ",
    "article_date": "November 5, 2021",
    "session_type": "615.Acute Myeloid Leukemias: Commercially Available Therapies, Excluding Transplantation and Cellular Immunotherapies",
    "abstract_text": "Background In a recent phase-III trial CPX-351 (Jazz Pharmaceuticals, Palo Alto, CA), a liposomal encapsulation of cytarabine and daunorubicin, has shown higher remission rates and longer overall survival (OS) in patients aged 60 to 75 years with AML with myelodysplasia-related changes (AML-MRC) or therapy-related AML (t-AML) in comparison to conventional 7+3 regimen. Based on this CPX-351 has been approved in the USA 2017 and in Europe 2018 for adult patients with newly-diagnosed AML-MRC or t-AML. Still, several issues such as age (<60 years), measurable residual disease (MRD), molecular subgroups and outcome after allo-HCT were not addressed in the phase-III trial. Aiming to investigate these open aspects and to provide more clinical experience with CPX-351, we performed a real-world analysis of patients with AML treated with CPX-351 as first-line therapy. Design/Methods: For this retrospective analysis, we collected data on baseline characteristics, treatment details including allo-HCT and outcome from patients with newly-diagnosed AML-MRC or t-AML, who were treated with CPX-351 according to the EMA label between 2018 and 2020 in 25 German centers participating in the Study Alliance Leukemia (SAL), German Cooperative Transplant Study Group and the AML Study Group (AMLSG). Results: A total of 188 patients (median age 65 years, range 26 to 80) with t-AML (29%) or AML-MRC (70%) including 46 patients (24%) <60 years could be analyzed. Eigthy-six percent received one, 14% two induction cycles and 10% received consolidation with CPX-351. Following induction, CR/CRi rate was 47% including 64% of patients with available information achieving measurable residual disease (MRD) negativity (<10-3) as measured by flow cytometry at local laboratories. Additionally, 35 patients were categorized as MLFS at first remission control, which achieved CRi (n=16) or CR (n=10) in the further course without additional therapy. After median follow-up of 9.3 months, median overall survival (OS) was 21 months and 1-year OS rate was 64%. In multivariate analysis, complex karyotype predicted lower response (p=.0001), and pretreatment with hypomethylating agents (p=.02) and adverse European LeukemiaNet 2017 genetic risk (p<.0001) were associated with lower OS. Allo-HCT was performed in 116 patients (62%) including 101 of these patients with CR prior transplant and resulted in 1-year OS of 73% (median survival not reached), especially in MRD negative patients (p=.048). With 69% of patients developing grade III/IV non-hematologic toxicity following induction and a day 30-mortality of 8% the safety profile was consistent with previous findings. Conclusion: The results from this real-world analysis confirm CPX-351 as an efficient treatment for these high-risk AML patients bridging to facilitating allo-HCT in many patients with encouraging outcome after transplantation. Disclosures R\u00f6llig:  AbbVie: Honoraria, Research Funding; Amgen: Honoraria; Bristol-Meyer-Squibb: Honoraria, Research Funding; Janssen: Honoraria; Jazz: Honoraria; Novartis: Honoraria, Research Funding; Pfizer: Honoraria, Research Funding; Roche: Honoraria, Research Funding. Stelljes:  Pfizer: Consultancy, Research Funding, Speakers Bureau; Amgen: Consultancy, Speakers Bureau; Medac: Speakers Bureau; Celgene/BMS: Consultancy, Speakers Bureau; Novartis: Consultancy, Speakers Bureau; MSD: Consultancy, Speakers Bureau; Kite/Gilead: Consultancy, Speakers Bureau. Gaidzik:  Janssen: Speakers Bureau; Pfizer: Speakers Bureau; Abbvie: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau. Unglaub:  Novartis: Consultancy, Other: travel costs/ conference fee; JazzPharma: Consultancy, Other: travel costs/ conference fee. Thol:  Abbvie: Honoraria; Astellas: Honoraria; BMS/Celgene: Honoraria, Research Funding; Jazz: Honoraria; Novartis: Honoraria; Pfizer: Honoraria. Krause:  Siemens: Research Funding; Takeda: Honoraria; Pfizer: Honoraria; art-tempi: Honoraria; Kosmas: Honoraria; Gilead: Other: travel support; Abbvie: Other: travel support. Haenel:  Celgene: Consultancy, Honoraria; Amgen: Consultancy; Novartis: Consultancy, Honoraria; Roche: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Bayer Vital: Honoraria; Jazz: Consultancy, Honoraria; GSK: Consultancy. Vucinic:  Novartis: Honoraria; Janssen: Honoraria, Other: Travel Sponsoring; Abbvie: Honoraria, Other: Travel Sponsoring; Gilead: Honoraria, Other: Travel Sponsoring; MSD: Honoraria. Fransecky:  Novartis: Honoraria; Medac: Honoraria; Abbvie: Honoraria, Research Funding; Amgen: Honoraria; Takeda: Honoraria. Holtick:  Celgene: Honoraria; Sanofi: Honoraria. Kobbe:  Celgene: Research Funding. Holderried:  Novartis: Consultancy, Membership on an entity's Board of Directors or advisory committees; GSK: Consultancy, Membership on an entity's Board of Directors or advisory committees; Amgen: Speakers Bureau; Gilead Sciences: Consultancy, Membership on an entity's Board of Directors or advisory committees; Sanofi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Celgene: Consultancy, Membership on an entity's Board of Directors or advisory committees; MSD: Speakers Bureau; Daiichi Sankyo: Other: travel support; Jazz Pharmaceuticals: Consultancy, Membership on an entity's Board of Directors or advisory committees; Therakos: Other: Travel support; Janssen: Other: Travel support; Abbvie: Other: Travel support; Eurocept Pharmaceuticals: Other: Travel support; Medac: Other: Travel support. Heuser:  Astellas: Research Funding; Bayer AG: Honoraria, Research Funding; BMS/Celgene: Research Funding; Jazz Pharmaceuticals: Honoraria, Research Funding; BergenBio: Research Funding; Daichi Sankyo: Honoraria, Research Funding; Karyopharm: Research Funding; Novartis: Honoraria, Research Funding; Pfizer: Honoraria, Research Funding; Roche: Research Funding; Tolremo: Honoraria; AbbVie: Honoraria; Janssen: Honoraria. Sauer:  Pfizer: Consultancy, Speakers Bureau; Abbvie: Consultancy, Speakers Bureau; Matterhorn Biosciences AG: Consultancy, Other: DSMB/SAB Member; Takeda: Consultancy, Other: DSMB/SAB Member. Goetze:  Abbvie: Other: Advisory Board; BMS/Celgene: Other: Advisory Board, Research Funding. D\u00f6hner:  Jazz Roche: Consultancy, Honoraria; Agios and Astex: Research Funding; Astellas: Research Funding; Abbvie: Consultancy, Honoraria; Janssen: Honoraria, Other: Advisory Board; Daiichi Sankyo: Honoraria, Other: Advisory Board; Novartis: Consultancy, Honoraria, Research Funding; Celgene/BMS: Consultancy, Honoraria, Research Funding. D\u00f6hner:  Jazz Pharmaceuticals: Honoraria, Research Funding; Agios: Honoraria, Research Funding; Pfizer: Research Funding; Bristol Myers Squibb: Honoraria, Research Funding; Abbvie: Honoraria, Research Funding; Novartis: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Gilead: Honoraria; Janssen: Honoraria; Helsinn: Honoraria; GEMoaB: Honoraria; Amgen: Honoraria, Research Funding; Astellas: Honoraria, Research Funding; Astex Pharmaceuticals: Honoraria; AstraZeneca: Honoraria; Berlin-Chemie: Honoraria; Oxford Biomedica: Honoraria; Roche: Honoraria. Schliemann:  Philogen S.p.A.: Consultancy, Honoraria, Research Funding; Abbvie: Consultancy, Other: travel grants; Astellas: Consultancy; AstraZeneca: Consultancy; Boehringer-Ingelheim: Research Funding; BMS: Consultancy, Other: travel grants; Jazz Pharmaceuticals: Consultancy, Research Funding; Novartis: Consultancy; Roche: Consultancy; Pfizer: Consultancy. Schetelig:  Roche: Honoraria, Other: lecture fees; Novartis: Honoraria, Other: lecture fees; BMS: Honoraria, Other: lecture fees; Abbvie: Honoraria, Other: lecture fees; AstraZeneca: Honoraria, Other: lecture fees; Gilead: Honoraria, Other: lecture fees; Janssen: Honoraria, Other: lecture fees . Germing:  Novartis: Honoraria, Research Funding; Janssen: Honoraria; Bristol-Myers Squibb: Honoraria, Other: advisory activity, Research Funding; Celgene: Honoraria; Jazz Pharmaceuticals: Honoraria. Schroeder:  JAZZ: Honoraria, Research Funding.",
    "author_names": [
        "Christina Rautenberg",
        "Friedrich St\u00f6lzel",
        "Christoph R\u00f6llig",
        "Matthias Stelljes",
        "Verena I Gaidzik",
        "Michael Lauseker",
        "Oliver Kriege",
        "Mareike Verbeek",
        "Julia M. Unglaub",
        "Felicitas Thol",
        "Stefan W. Krause",
        "Mathias Haenel",
        "Charlotte Neuerburg",
        "Vladan Vucinic",
        "Christian Jehn",
        "Julia Severmann",
        "Maxi Wass",
        "Lars Fransecky",
        "Jens Chemnitz",
        "Udo Holtick",
        "Kerstin Sch\u00e4fer-Eckart",
        "Josephine Schr\u00f6der",
        "Sabrina Kraus",
        "William Hermann Kr\u00fcger",
        "Ulrich Kaiser",
        "Sebastian Scholl",
        "Lea Henning",
        "Guido Kobbe",
        "Rainer Haas",
        "Nael Alakel",
        "Maximilian Alexander R\u00f6hnert",
        "Katja Sockel",
        "Maher Hanoun",
        "Uwe Platzbecker",
        "Tobias A. W. Holderried",
        "Anke Morgner",
        "Michael Heuser",
        "Tim Sauer",
        "Katharina S. Goetze",
        "Eva Maria Wagner",
        "Konstanze D\u00f6hner",
        "Hartmut D\u00f6hner",
        "Christoph Schliemann",
        "Johannes Schetelig",
        "Martin Bornh\u00e4user",
        "Ulrich Germing",
        "Thomas Schroeder",
        "Moritz Moritz Middeke"
    ],
    "author_dict_list": [
        {
            "author_name": "Christina Rautenberg",
            "author_affiliations": [
                "Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Friedrich St\u00f6lzel",
            "author_affiliations": [
                "Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dre, Dresden, DEU"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christoph R\u00f6llig",
            "author_affiliations": [
                "Medical Department I, University Hospital, Dresden, Germany"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Matthias Stelljes",
            "author_affiliations": [
                "Department of Medicine A, Hematology, Oncology and Pneumology, University of Muenster, Muenster, Germany"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Verena I Gaidzik",
            "author_affiliations": [
                "Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael Lauseker",
            "author_affiliations": [
                "Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Oliver Kriege",
            "author_affiliations": [
                "Department of Hematology, Oncology, Pneumology, Medical Clinic III, UCT Johannes Gutenberg-University, Mainz, Germany"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mareike Verbeek",
            "author_affiliations": [
                "Technische Universitaet Muenchen, Munich, DEU"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julia M. Unglaub",
            "author_affiliations": [
                "University Hospital Heidelberg, Heidelberg, Germany"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Felicitas Thol",
            "author_affiliations": [
                "Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefan W. Krause",
            "author_affiliations": [
                "Department of Hematology and Medical Oncology, University Hospital Erlangen, Erlangen, Germany"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mathias Haenel",
            "author_affiliations": [
                "Klinik f\u00fcr Innere Medizin III, KLINIKUM CHEMNITZ GGMBH, Chemnitz, Germany",
                "Klinikum Chemnitz, Chemnitz, Germany"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Charlotte Neuerburg",
            "author_affiliations": [
                "University Hospital Bonn, Bonn, Germany"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vladan Vucinic",
            "author_affiliations": [
                "Clinic and Policlinic for Hematology and Cellular Therapy, University of Leipzig Medical Center, Leipzig, Germany"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christian Jehn",
            "author_affiliations": [
                "Asklepios Hamburg, Hamburg, Germany"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Julia Severmann",
            "author_affiliations": [
                "University Hospital Essen, Essen, Germany"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maxi Wass",
            "author_affiliations": [
                "Hematology and Oncology, University Hospital of Halle (Saale), Halle (Saale), Germany"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lars Fransecky",
            "author_affiliations": [
                "Klinik f\u00fcr Innere Medizin II, Universit\u00e4tsklinikum Schleswig-Holstein, Kiel, Germany"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jens Chemnitz",
            "author_affiliations": [
                "Gemeinschaftsklinikum Mittelrhein GmbH, Koblenz, Germany"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Udo Holtick",
            "author_affiliations": [
                "Department I of Internal Medicine, University of Cologne, Cologne, DEU"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Kerstin Sch\u00e4fer-Eckart",
            "author_affiliations": [
                "Klinikum N\u00fcrnberg, N\u00fcrnberg, Germany"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Josephine Schr\u00f6der",
            "author_affiliations": [
                "Helios Berlin Buch, Berlin, Germany"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabrina Kraus",
            "author_affiliations": [
                "Department of Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "William Hermann Kr\u00fcger",
            "author_affiliations": [
                "Universit\u00e4tsmedizin Greifswald, Greifswald, Germany"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ulrich Kaiser",
            "author_affiliations": [
                "Bernward Krankenhaus, Bernward, Germany"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sebastian Scholl",
            "author_affiliations": [
                "University Hospital Jena, Jena, Germany"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lea Henning",
            "author_affiliations": [
                "UK Essen, Essen, Germany"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Guido Kobbe",
            "author_affiliations": [
                "Department of Hematology, Oncology and Clinical Immunology, University Hospital D\u00fcsseldorf, Medical Faculty, Heinrich Heine University, D\u00fcsseldorf, Germany"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rainer Haas",
            "author_affiliations": [
                "Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University D\u00fcsseldorf, D\u00fcsseldorf, Germany"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nael Alakel",
            "author_affiliations": [
                "University of Dresden, Dresden, DEU"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maximilian Alexander R\u00f6hnert",
            "author_affiliations": [
                "Department of Internal Medicine I, University Hospital Carl-Gustav-Carus Dresden, Dresden, Germany"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Katja Sockel",
            "author_affiliations": [
                "Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany"
            ],
            "author_rank": 32,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maher Hanoun",
            "author_affiliations": [
                "Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany"
            ],
            "author_rank": 33,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Uwe Platzbecker",
            "author_affiliations": [
                "University of Leipzig Medical Center, Leipzig, Germany"
            ],
            "author_rank": 34,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tobias A. W. Holderried",
            "author_affiliations": [
                "Department of Hematology, Oncology, Immunoncology and Rheumatology / Internal Medicine III, University Hospital Bonn, Bonn, Germany"
            ],
            "author_rank": 35,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anke Morgner",
            "author_affiliations": [
                "Klinikum Chemnitz, Chemnitz, Germany"
            ],
            "author_rank": 36,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Michael Heuser",
            "author_affiliations": [
                "Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany"
            ],
            "author_rank": 37,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tim Sauer",
            "author_affiliations": [
                "Internal Medicine V - Hematology, Oncology & Rheumatology, University Hospital Heidelberg, Heidelberg, Germany"
            ],
            "author_rank": 38,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Katharina S. Goetze",
            "author_affiliations": [
                "Department of Medicine III, Technical University of Munich, Klinikum Rechts Der Isar, Munich, Germany"
            ],
            "author_rank": 39,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Eva Maria Wagner",
            "author_affiliations": [
                "University Hospital Mainz, Universit\u00e4ren Centrums f\u00fcr Tumorerkrankungen, Mainz, Germany"
            ],
            "author_rank": 40,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Konstanze D\u00f6hner",
            "author_affiliations": [
                "University Hospital of Ulm, Ulm, Germany"
            ],
            "author_rank": 41,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Hartmut D\u00f6hner",
            "author_affiliations": [
                "Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany"
            ],
            "author_rank": 42,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Christoph Schliemann",
            "author_affiliations": [
                "Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany"
            ],
            "author_rank": 43,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Johannes Schetelig",
            "author_affiliations": [
                "Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany"
            ],
            "author_rank": 44,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martin Bornh\u00e4user",
            "author_affiliations": [
                "Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany"
            ],
            "author_rank": 45,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ulrich Germing",
            "author_affiliations": [
                "University Hospital of D\u00fcsseldorf, D\u00fcsseldorf, Germany"
            ],
            "author_rank": 46,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Thomas Schroeder",
            "author_affiliations": [
                "Hematology and Stem Cell Transplantation, Duisburg, Germany"
            ],
            "author_rank": 47,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Moritz Moritz Middeke",
            "author_affiliations": [
                "Medizinische Klinik I, Universitaetsklinikum C.G.Carus, Dresden, Germany"
            ],
            "author_rank": 48,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T09:34:23",
    "is_scraped": "1"
}